RebrAIn

RebrAIn is a medical technology company dedicated to improving neurosurgical outcomes for patients with Parkinson’s disease and Essential Tremor. Founded by experts in neurosurgery and applied mathematics, the company emerged as a spin-off from the University Hospital of Bordeaux and Inria. RebrAIn offers AI-driven software-as-a-medical-device solutions, including OptimMRI and OptimDBS, which facilitate precise brain targeting for deep brain stimulation and lesioning procedures. Their technology integrates supervised AI algorithms with a health data exchange platform, enhancing the pre-surgical planning process for neurosurgeons. The company has achieved significant regulatory milestones, including CE marking and FDA 510(k) clearance, ensuring the safety and efficacy of its products. With over 55 clinical sites adopting their solutions and more than 500 surgeries performed, RebrAIn is making a notable impact in the treatment of movement disorders across Europe and the United States.

• Employees14
• Founded2021